阿里巴巴(BABA.US)盤前漲1.47% 發佈自研5nm雲芯片倚天710
格隆匯10月19日丨阿里巴巴(BABA.US)盤前漲1.47%報169.28美元。港股阿里巴巴(9988.HK)今日收漲1.17%報164.8港元,折算成美股市場價格為169.54美元/ADS。在今日召開的2021雲棲大會現場,阿里巴巴旗下半導體公司平頭哥發佈自研雲芯片倚天710。該芯片是首款採用業界最先進5nm工藝的ARM服務器芯片,性能超過業界標杆20%,能效比提升50%以上。倚天710是阿里雲推進“一雲多芯”策略的重要一步,也是阿里第一顆為雲而生的CPU芯片,將在阿里雲數據中心部署應用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.